Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
871 participants
INTERVENTIONAL
2022-04-18
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
NCT00535678
Trial of a Mammography Decision Aid for Women Aged 75 and Older
NCT02198690
Prospective Case Collection Study for New Mammography Technologies
NCT05199701
Communicating Objective Risk for Personalized Decision Making About Mammography
NCT01686360
Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography
NCT00535327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Average risk female Veterans who are due for breast cancer screening (defined as aged 45-75 with no previous history of bilateral mastectomy, not under hospice care, and alive at the time of screening) will be identified through administrative data.
Veterans eligible for enrollment into the trial will be randomized in a 1:1 allocation using permuted block randomization (with random block sizes of 2 and 4) to the following interventions:
Arm 1: Automated phone opt-in message Intervention Type: Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent Arm 2: Opt-out scheduling Intervention Type: Consult automatically sent and Veteran called to schedule screening
Randomization will be stratified within arms by prior screening status (prior screener vs. never screener).
The study's primary outcome of interest is screening completion at 100 days post randomization. The study's secondary outcome of interest is screening scheduling at 100 days post randomization. Subgroup analysis aim 1 will explore whether the differences in breast cancer screening completion between investigational groups varies according to the Veterans' race/ethnicity. Subgroup analysis aim 2 will explore whether the differences in breast cancer screening scheduling between investigational groups varies according to the Veterans' race/ethnicity. Enrollment in the trial will occur between March 1, 2022 and August 31, 2022.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Automated phone opt-in message
Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent
Automated message
Automated message via phone call (audiocare)
Opt-out scheduling
Consult automatically sent and Veteran called to schedule screening
Opt-out scheduling
Scheduling via non-automated phone call
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Automated message
Automated message via phone call (audiocare)
Opt-out scheduling
Scheduling via non-automated phone call
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* assigned to a primary care provider at the VA Puget Sound as of January 1, 2022 with at least 1 year of prior data available
* due for breast cancer screening (have not had a mammogram in the last 12 months)
Exclusion Criteria
* no record of recent death in the administrative data
* not scheduled for either a screening or diagnostic mammogram within the following 12 weeks from assessment.
* not have a personal history of bilateral mastectomy.
45 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Puget Sound Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaina Mori
Staff Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashok Reddy, MD
Role: PRINCIPAL_INVESTIGATOR
VA Puget Sound Health Care System
Stefanie Deeds, MD
Role: PRINCIPAL_INVESTIGATOR
VA Puget Sound Health Care System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Puget Sound Health Care System
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Marcotte LM, Deeds S, Wheat C, Gunnink E, Gray K, Rojas J, Finch C, Nelson K, Reddy A. Automated Opt-Out vs Opt-In Patient Outreach Strategies for Breast Cancer Screening: A Randomized Clinical Trial. JAMA Intern Med. 2023 Nov 1;183(11):1187-1194. doi: 10.1001/jamainternmed.2023.4321.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAMMoutreach
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.